SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate risk on Outcome Utilizing 2.2014 NCCN Risk Stratif...

by Matthew eBernetich, Matthew eBernetich, Caspian eOliai, Rachelle eLanciano, Rachelle eLanciano, Rachelle eLanciano, Alexandra eHanlon, John eLamond, John eLamond, Stephen eArrigo, Stephen eArrigo, Jun eYang, Jun eYang, Michael eGood, Jing eFeng, Royce eBrown, Bruce eGarber, Michael eMooreville, Luther W. Brady, Luther W. Brady
Published 2014-11-01